Bing

SEARCH HISTORY

Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... Click Here Now Array BioPharma (NASDAQ: ARRY ) was trading at multiyear highs in July after the company announced positive phase 2 data for its experimental drug …
The Motley Fool · 10/7/2013
Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. On Friday, Array BioPharma rose 11.74% to $2.38 …
Smallcap Network · ByJohn Udovich · 4/23/2012
... and six have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $9.60. Shares of Array Biopharma (NASDAQ:ARRY) opened at 7.145 on Tuesday. Array Biopharma has …
wkrb13.com · 5/5/2015
More from Bing News
Shares of Array Biopharma, Inc. (NASDAQ: ARRY) are falling after the close Wednesday after the company disclsoed it entered into a Sales Agreement for an at-the-market offering of shares of our common stock with Cantor Fitzgerald & Co., as sales agent ...
StreetInsider · 3/27/2013
Piper Jaffray set a $15.00 price target on Array Biopharma (NASDAQ:ARRY) in a research note issued to investors on Tuesday. The firm currently has a a buy rating on the biopharmaceutical company’s stock. Array Biopharma (NASDAQ:ARRY) opened …
sleekmoney.com · 6/4/2015
To read the entire report visit: www.microstockprofit.com/ads/ARRY See what investors are saying about ARRY at penny stock forum MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to …
GlobeNewswire · 4/21/2010
Array Biopharma Inc (NASDAQ:ARRY) hit a six-year high of $7.58 earlier ... is safely north of recent congestion in the $5 region. Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations ...
Schaeffer's Investment Research · 1/23/2015
The third best-performing: Array Biopharma Inc (NASDAQ: ARRY). Array focuses on the discovery ... That’s an 80 percent rise. The biotech stocks considered for this review were confined to those over $5 per share that traded at least 500K shares a ...
Benzinga · 2/2/2015
Vale S.A. (VALE) of the Basic Materials sector is down -5.41% (change from open -0.73%) this morning trading at a volume of 3,109,957 shares and price of $8.22. Vale S.A. (VALE)’s weekly performance is 8.22% and compared to their 52 week low, they …
wallstreetscope.com · 1/23/2015
Dr. K. C. Nicolaou, Ph.D., serves as Scientific and Clinical Advisor of Anadys Pharmaceuticals Inc. Dr. Nicolaou Co-Founded Array Biopharma Inc. in 1998. He is a Professor of Chemistry and has been Chairman of the Department of Chemistry from …
Bloomberg · 6/26/2015